Mighty Therapeutics
therapeutics Megan Prock McGrath therapeutics Megan Prock McGrath

Mighty Therapeutics

Mighty Therapeutics, together with its wholly owned operating subsidiary, Stealth BioTherapeutics Inc., is advancing novel therapies for people living with diseases involving mitochondrial dysfunction.

Read More
Apella
other Megan Prock McGrath other Megan Prock McGrath

Apella

Powered by ambient AI and integrated with the EHR, Apella gives surgical teams the ground-truth data needed to serve more patients and still go home on time.

Read More
Neumora Therapeutics (NASDAQ: NMRA)
therapeutics Megan Prock McGrath therapeutics Megan Prock McGrath

Neumora Therapeutics (NASDAQ: NMRA)

Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed.

Read More
Umoja Biopharma
therapeutics Megan Prock McGrath therapeutics Megan Prock McGrath

Umoja Biopharma

Clinical-stage biotechnology company aiming to develop in vivo cell therapies that improve the reach, effectiveness, and access of CAR T cell therapies in both oncology and autoimmunity.

Read More